Home > Financial Ratios > VAISHALI PHARMA

VAISHALI PHARMA
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for VAISHALI PHARMA
Please provide your vote to see the results

VAISHALI PHARMA Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -68.1133.8294.6045.00-24.35

What is the latest Core EBITDA Growth ratio of VAISHALI PHARMA ?

The latest Core EBITDA Growth ratio of VAISHALI PHARMA is -68.11 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar2024-68.11
Mar202333.82
Mar202294.60
Mar202145.00
Mar2020-24.35

How is Core EBITDA Growth of VAISHALI PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2024 -68.11
Negative
Mar2023 33.82
-64.25
Mar2022 94.6
110.22
Mar2021 45
Positive
Mar2020 -24.35 -

Other Financial Ratios of VAISHALI PHARMA


Compare Core EBITDA Growth ratio of peers of VAISHALI PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VAISHALI PHARMA ₹158.0 Cr -6.6% -2.9% -24.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹389,172.0 Cr 1.8% -3.6% -7.1% Stock Analytics
DIVIS LABORATORIES ₹158,248.0 Cr -2.8% -12.1% 24% Stock Analytics
CIPLA ₹122,835.0 Cr 2.3% 2.4% -4.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,793.0 Cr 2.9% 6.5% 8.3% Stock Analytics
DR REDDYS LABORATORIES ₹101,869.0 Cr 2% -2.4% -13.1% Stock Analytics


VAISHALI PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VAISHALI PHARMA

-6.6%

-2.9%

-24.2%

SENSEX

-0.6%

-2.8%

1.7%


You may also like the below Video Courses